STERIS Plc (Ireland)

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IE00BFY8C754
USD
202.61
3.21 (1.61%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,588.40
1,496.20
1,460.30
1,391.10
1,480.53
1,370.57
1,328.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,588.40
1,496.20
1,460.30
1,391.10
1,480.53
1,370.57
1,328.91
Raw Material Cost
855.70
841.10
815.40
762.90
825.08
760.58
747.42
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.10
14.90
14.90
15.90
17.11
19.09
19.67
Selling and Distribution Expenses
350.00
348.70
347.80
354.90
333.68
332.01
329.17
Other Expenses
1.37
1.46
1.33
1.05
1.06
0.83
0.74
Total Expenditure (Excl Depreciation)
1,234.50
1,219.30
1,191.40
1,144.20
1,186.44
1,119.95
1,103.62
Operating Profit (PBDIT) excl Other Income
353.9
276.90000000000003
268.9
246.9
294.1
250.6
225.3
Other Income
2.80
-0.40
2.10
1.90
-3.51
3.32
-5.05
Operating Profit (PBDIT)
480.10
398.50
392.70
368.20
412.93
379.86
335.50
Interest
15.10
14.90
14.90
15.90
17.11
19.09
19.67
Exceptional Items
-37.10
-3.60
-3.00
-1.00
-76.16
-6.11
-5.68
Gross Profit (PBDT)
732.70
655.10
644.90
628.20
655.45
609.99
581.50
Depreciation
123.40
122.00
121.70
119.40
122.35
125.91
115.25
Profit Before Tax
304.50
257.80
253.10
231.90
197.31
228.75
194.89
Tax
84.20
63.50
60.60
53.90
50.45
55.38
43.51
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
220.30
192.90
191.90
177.40
146.46
173.61
150.25
Extraordinary Items
0.00
0.00
0.00
0.00
-0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
220.30
192.90
191.90
177.40
146.46
173.61
150.25
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.10
1.50
0.60
0.60
0.40
-0.25
1.14
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
220.40
194.40
192.50
178.00
146.86
173.36
151.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
7,183.60
7,154.50
7,009.10
6,957.00
6,603.40
6,416.10
6,593.49
Earnings per share (EPS)
2.24
1.96
1.94
1.8
1.53
1.75
1.51
Diluted Earnings per share
2.24
1.96
1.94
1.8
1.53
1.75
1.51
Operating Profit Margin (Excl OI)
22.28%
18.51%
18.41%
17.75%
19.86%
18.29%
16.95%
Gross Profit Margin
26.94%
25.38%
25.67%
25.25%
21.59%
25.88%
23.34%
PAT Margin
13.87%
12.89%
13.14%
12.75%
9.89%
12.67%
11.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 7.29% vs 4.30% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 50.03% vs -4.17% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 14.63% vs 9.78% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -11.70% vs -52.63% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of STERIS Plc (Ireland) With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,588.40
1,431.41
156.99
10.97%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,588.40
1,431.41
156.99
10.97%
Raw Material Cost
855.70
551.67
304.03
55.11%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
15.10
0.00
15.10
Selling and Distribution Expenses
350.00
279.75
70.25
25.11%
Other Expenses
1.37
9.43
-8.06
-85.47%
Total Expenditure (Excl Depreciation)
1,234.50
925.70
308.80
33.36%
Operating Profit (PBDIT) excl Other Income
353.90
505.71
-151.81
-30.02%
Other Income
2.80
-5.55
8.35
150.45%
Operating Profit (PBDIT)
480.10
569.19
-89.09
-15.65%
Interest
15.10
0.00
15.10
Exceptional Items
-37.10
2.15
-39.25
-1,825.58%
Gross Profit (PBDT)
732.70
879.73
-147.03
-16.71%
Depreciation
123.40
69.03
54.37
78.76%
Profit Before Tax
304.50
502.31
-197.81
-39.38%
Tax
84.20
103.58
-19.38
-18.71%
Provisions and contingencies
0
0
0.00
Profit After Tax
220.30
398.73
-178.43
-44.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
220.30
398.73
-178.43
-44.75%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.10
0.00
0.10
Other related items
0.00
0.00
0.00
Consolidated Net Profit
220.40
398.73
-178.33
-44.72%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
7,183.60
6,491.91
691.69
10.65%
Earnings per share (EPS)
2.24
2.74
-0.50
-18.25%
Diluted Earnings per share
2.24
2.74
-0.50
-18.25%
Operating Profit Margin (Excl OI)
22.28%
35.33%
0.00
-13.05%
Gross Profit Margin
26.94%
39.91%
0.00
-12.97%
PAT Margin
13.87%
27.86%
0.00
-13.99%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 158.84 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 6.16% vs 2.46% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 7.29% vs 4.30% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 22.04 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 13.37% vs 0.99% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 50.03% vs -4.17% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 47.73 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 19.65% vs 2.12% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 14.63% vs 9.78% in Mar 2025

Quarterly - Interest
Interest 1.51 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 1.34% vs 0.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -11.70% vs -52.63% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.28%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025